Kurihara, Kazuya
Iriyama, Noriyoshi http://orcid.org/0000-0001-9176-1988
Miura, Katsuhiro
Uchino, Yoshihito
Takahashi, Hiromichi
Nakagawa, Masaru
Iizuka, Kazuhide
Hamada, Takashi
Koike, Takashi
Hatta, Yoshihiro
Nakayama, Tomohiro
Takei, Masami
Article History
Received: 9 April 2019
Accepted: 17 July 2019
First Online: 24 July 2019
Compliance with ethical standards
:
: NI received honoraria and speaker fees from Bristol-Myers Squibb, Celgene K.K., Takeda Pharma Co., Ltd., and Ono Parma Co., Ltd. KM received honoraria and speaker fees from Celgene K.K., Takeda Pharma Co., Ltd., and Ono Parma Co., Ltd. HT, MN, and TH reports honoraria and speaker fees from Bristol-Myers Squibb. YH received speaker fees and honoraria from Celgene K.K., Janssen Pharmaceutical K.K., Bristol-Myers Squibb, Takeda Pharma Co., Ltd., and Ono Parma Co., Ltd. MT received honoraria from Janssen Pharmaceutical K.K., Bristol-Myers Squibb, Takeda Pharma Co., Ltd., and Ono Parma Co., Ltd., supports for extension lectures from Bristol-Myers Squibb, and scholarship funds from Takeda Pharma Co., Ltd. and Ono Parma Co., Ltd. In addition, MT is part of an international clinical trial evaluating an investigational drug that was developed by Bristol-Myers Squibb for the treatment of Sjögren’s syndrome and has cooperative research with Celgene K.K. The remaining co-authors declare no competing financial interests.
: All procedures were performed in accordance with the ethical standards of the Institutional Research Committee of the Nihon University Itabashi Hospital and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Written informed consent was not required due to retrospective nature of this study.